Clobazam monotherapy for focal or generalized seizures.
CONCLUSIONS: We found no advantage for clobazam over carbamazepine for retention at 12 months in drug-naive children and a slight advantage of clobazam over phenytoin for retention at six months in adolescents and adults with neurocysticercosis in a single clinical trial each. At present, the available evidence is insufficient to inform clinical practice.
PMID: 29995989 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Arya R, Giridharan N, Anand V, Garg SK Tags: Cochrane Database Syst Rev Source Type: research
More News: Brain | Carbamazepine | Children | Clinical Trials | Databases & Libraries | Epilepsy | General Medicine | International Medicine & Public Health | Neurology | Phenytoin | Statistics | Study | WHO